Characterization of exosomes from hypoxia-activated human amniotic membrane mesenchymal stem cells

Document Type : Original Article

Authors

1 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

2 Department of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran

3 Department of Medical Laser (MLRC), Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran

4 Department of Biology, Shahid Beheshti University, Tehran, Iran

5 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

6 Department of Regenerative Medicine in Wound Healing, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran

10.22038/ijbms.2026.90923.19618

Abstract

Objective(s): Hypoxia is a physical stimulus that enhances stem cell activities to produce more cellular derivatives, particularly exosomes. Enhancing the quantity and quality of exosomes can improve their therapeutic properties. The study aimed to evaluate the effects of normoxic (22%O2) and hypoxic (1%O2) conditions on the characteristics of amniotic membrane-derived mesenchymal stem cells (AM-MSCs) and their exosomes.
Materials and Methods: AM-MSCs were isolated, confirmed, and cultured under normoxic and hypoxic conditions. Exosomes were extracted from AM-MSCs and assessed for morphological characteristics (size/distribution/surface topography), structural properties (aggregation/colloidal particle behavior/surface charge/stability), chemical features (functional groups/ionic interactions), biological capacities (total protein concentration), and biocompatibility (microbiological quality/cytotoxicity/irritation/sensitization). 
Results: Hypoxia did not adversely affect the stemness potential of AM-MSCs (P>0.05). The average sizes of exosomes derived from AM-MSCs (AM-MSCs-Exo) were 185.7±23 nm (PI=0.756) and 145.4±36 nm (PI=0.420) under normoxic and hypoxic conditions, respectively (P≤0.05). Zeta potential of AM-MSCs-Exo was -12.57±0.5 mV under normoxia, while it was -2.37±0.73 mV in the hypoxic conditions. Exosomes from hypoxia-treated cells exhibited greater uniformity, dispersion, and stability than those from the normoxic group, resulting in reduced fluctuation under scattered light over time (P≤0.05). The total protein concentration in the hypoxic group was significantly higher than in the normoxic conditions (5.003 mg/ml vs. 4.109 mg/ml, representing a 1.22-fold increase) (P≤0.01). Exosomes extracted under normoxic and hypoxic conditions demonstrated acceptable biocompatibility with no signs of cytotoxicity, irritation, sensitivity, or microbial contamination.
Conclusion: Hypoxic preconditioning enhances the yield and physicochemical stability of AM-MSC-derived exosomes, due to their unique composition and functional properties. 

Keywords

Main Subjects


1. Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther 2016; 7:125.
2. Lee DE, Ayoub N, Agrawal DK. Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy. Stem Cell Res Ther 2016; 7:37.
3. Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci 2017;18:1852.
4. Vishnubalaji R, Al-Nbaheen M, Kadalmani B, Aldahmash A, Ramesh T. Skin-derived multipotent stromal cells–an archrival for mesenchymal stem cells. Cell Tissue Res 2012; 350:1-12.
5. Maharlooei MK, Bagheri M, Solhjou Z, Jahromi BM, Akrami M, Rohani L, et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res Clin Pract 2011; 93:228-234.
6. Kemp KC, Hows J, Donaldson C. Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 2005; 46:1531-1544.
7. Ledesma-Martínez E, Mendoza-Núñez VM, Santiago-Osorio E. Mesenchymal stem cells derived from dental pulp: a review. Stem Cells Int 2016; 2016:4709572.
8. Kim EY, Lee K-B, Kim MK. The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy. BMB Rep 2014; 47:135.
9. Heidari B, Shirazi A, Akhondi MM, Hassanpour H, Behzadi B, Naderi MM, et al. Comparison of proliferative and multilineage differentiation potential of sheep mesenchymal stem cells derived from bone marrow, liver, and adipose tissue. Avicenna J Med Biotechnol 2013; 5:104.
10. Schosserer M, Reynoso R, Wally V, Jug B, Kantner V, Weilner S, et al. Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa. BMC Res Notes 2015; 8:1-12.
11. Dittmer J, Leyh B. Paracrine effects of stem cells in wound healing and cancer progression. Int J Oncol 2014; 44:1789-1798.
12. Zhang J, Guan J, Niu X, Hu G, Guo S, Li Q, et al. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med 2015; 13:1-14.
13. Lopez-Verrilli MA, Caviedes A, Cabrera A, Sandoval S, Wyneken U, Khoury M. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience 2016; 320:129-139.
14. Bai L, Shao H, Wang H, Zhang Z, Su C, Dong L, et al. Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis. Sci Rep 2017; 7:4323.
15. Mitchell R, Mellows B, Sheard J, Antonioli M, Kretz O, Chambers D, et al. Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res Ther 2019; 10:1-19.
16. Kumar P, Kandoi S, Misra R, Vijayalakshmi S, Rajagopal K, Verma RS. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev 2019; 46:1-9.
17. Lombardi F, Palumbo P, Augello FR, Cifone MG, Cinque B, Giuliani M. Secretome of adipose tissue-derived stem cells (ASCs) as a novel trend in chronic non-healing wounds: an overview of experimental in vitro and in vivo studies and methodological variables. Int J Mol Sci 2019; 20:3721.
18. Iranian Food and Drug Administration. Guideline for extracellular vesicle studies [Internet]. Tehran: Ministry of Health and Medical Education; 2025 [cited 2025 Mar 8]. No.: GUI-DPNA-BIO-012; SOP-DPNA-BIO-001. Available from: https://fdo.sbmu.ac.ir
19. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science 2020; 7:367.
20. Zhang J, Guan J, Niu X, Hu G, Guo S, Li Q, et al. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med 2015; 13:49.
21. Lopez-Verrilli MA, Caviedes A, Cabrera A, Sandoval S, Wyneken U, Khoury M. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience 2016; 320:129-139.
22. Yáñez-Mó M, Siljander PRM, Andreu Z, Bedina Zavec A, Borràs FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015; 4:27066.
23. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell 2019; 177:428-445. e418.
24. Bec N, Bonhoure A, Henry L, Berry L, Larroque C, Coux O, et al. Proteasome 19S RP and translation preinitiation complexes are secreted within exosomes upon serum starvation. Traffic 2019; 20:516-536.
25. Garcia NA, Ontoria-Oviedo I, González-King H, Diez-Juan A, Sepúlveda P. Glucose starvation in cardiomyocytes enhances exosome secretion and promotes angiogenesis in endothelial cells. PLoS One 2015; 10:e0138849.
26. Yang R, Li Z, Xu J, Luo J, Qu Z, Chen X, et al. Role of hypoxic exosomes and the mechanisms of exosome release in the CNS under hypoxic conditions. Front Neurol 2023; 14: 1198546.
27. Jafari R, Rahbarghazi R, Ahmadi M, Hassanpour M, Rezaie J. Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications. J Transl Med 2020; 18:474.
28. Banerjee J, Sen CK. microRNA and wound healing. Adv Exp Med Biol 2015; 888:291-305.
29. Mu J, Li L, Wu J, Huang T, Zhang Y, Cao J, et al. Hypoxia-stimulated mesenchymal stem cell-derived exosomes loaded by adhesive hydrogel for effective angiogenic treatment of spinal cord injury. Biomater Sci 2022; 10:1803-1811.
30. Yuan N, Ge Z, Ji W, Li J. Exosomes secreted from hypoxia-preconditioned mesenchymal stem cells prevent steroid-induced osteonecrosis of the femoral head by promoting angiogenesis in rats. Biomed Res Int 2021; 2021:6655225.
31. Baglio SR, Rooijers K, Koppers-Lalic D, Verweij FJ, Pérez Lanzón M, Zini N, et al. Human bone marrow-and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 2015; 6:1-20.
32. He G, Peng X, Wei S, Yang S, Li X, Huang M, et al. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol Cancer 2022; 21:19.
33. Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z, et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater 2020; 103:196-212.
34. Wang J, Wu H, Peng Y, Zhao Y, Qin Y, Zhang Y, et al. Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K/Akt pathways. J Nanobiotechnol 2021; 19:1-13.
35. Guo W, Qiao T, Dong B, Li T, Liu Q, Xu X. The effect of hypoxia-induced exosomes on anti-tumor immunity and its implication for immunotherapy. Front Immunol 2022; 13:915985.
36. Kumar A, Deep G. Exosomes in hypoxia-induced remodeling of the tumor microenvironment. Cancer lett 2020; 488:1-8.
37. Heidari B, Shams S, Akbari N, Zandsalimi K. Three‑dimensionally decellularized human amniotic membrane scaffold: structure, processing, and biological properties. Cell Tissue Bank 2025;26:47. 
38. Karimi M, Heidari B, Jafary H, Zandsalimi K. The quality and quantity of nanoparticles extracted from human adipose tissue‑derived mesenchymal stem cells. Avicenna J Med Biotech 2025;17:186‑195. 
39. Rafighdoust Z, Baharara J, Forghanifard MM, Kerachian MA. Isolation and characterization of exosomes derived from breast cancer MDA-MB-231 cell line. Gene Cell Tissue 2021; 8:e110505.
40. United States Pharmacopeial Convention. United States Pharmacopeia 47–National Formulary 42 (USP 47–NF 42). Rockville (MD): United States Pharmacopeial Convention; 2024.
41. King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 2012; 12:421.
42. Zhang W, Zhou X, Yao Q, Liu Y, Zhang H, Dong Z. HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells. Am J Physiol Renal Physiol 2017; 313:F906-F913.
43. Moore TL, Rodriguez-Lorenzo L, Hirsch V, Balog S, Urban D, Jud C, et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev 2015; 44:6287-6305.
44. Bhattacharjee S. DLS and zeta potential – what they are and what they are not? J Control Release 2016; 235:337-351.
45. Jiang H, Zhao H, Zhang M, He Y, Li X, Xu Y, et al. Hypoxia induced changes of exosome cargo and subsequent biological effects. Front Immunol 2022; 13:824188.
46. Ridolfi A, Cardellini J, Gashi F, van Herwijnen MJC, Trulsson M, Campos-Terán J, et al. Electrostatic interactions control the adsorption of extracellular vesicles onto supported lipid bilayers. J Colloid Interface Sci 2023; 650:883-891.
47. Ramos-Garcia V, Ten-Doménech I, Moreno-Giménez A, Gormaz M, Parra-Llorca A, Shephard AP, et al. ATR-FTIR spectroscopy for the routine quality control of exosome isolations. Chemom Intell Lab Syst 2021; 217:104401.
48. Zlotogorski-Hurvitz A, Dekel BZ, Malonek D, Yahalom R, Vered M. FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer. J Cancer Res Clin Oncol 2019; 145:685-694.
49. Dash M, Palaniyandi K, Ramalingam S, Sahabudeen S, Raja NS. Exosomes isolated from two different cell lines using three different isolation techniques show variation in physical and molecular characteristics. Biochim Biophys Acta Biomembr 2021; 1863:183490.
50. Kim JY, Rhim W-K, Yoo Y-I, Kim D-S, Ko K-W, Heo Y, et al. Defined MSC exosome with high yield and purity to improve regenerative activity. J Tissue Eng 2021; 12:20417314211008626.
51. Xiao Y, Zou D, Liu J, Dai F, Zhao A, Yang P. Dose-responsive effects of endothelial cell-sourced exosomes on vascular cell proliferation and phenotype transition. Biochim Biophys Acta Gene Subj 2025; 1869:130745.
52. Shi Y, Chen Y, Wang Y, Mo D, Ai H, Zhang J, et al. Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors. J Nanobiotechnology 2024; 22:447.
53. Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 2019; 8:307.
54. Tseng YJ, Huang HJ, Lin CH, Lin AM. A double-edged effect of hypoxia on astrocyte-derived exosome releases. Exp Biol Med (Maywood) 2025; 250:10559.
55. El Sadik A, ALsaykhan HM, Alorini M, Hamouda N, Elzainy A. Prognostic impact of dose‑dependent exosomes derived from mesenchymal stem cells. J Med Pharm Chem Res 2025;7:2689‑2709. 
56. Wu J, Yu L, Liu Y, Xiao B, Ye X, Zhao H, et al. Hypoxia regulates adipose mesenchymal stem cells proliferation, migration, and nucleus pulposus-like differentiation by regulating endoplasmic reticulum stress via the HIF-1α pathway. J Orthop Surg Res 2023; 18:339.
57. Eliasson P, Rehn M, Hammar P, Larsson P, Sirenko O, Flippin LA, et al. Hypoxia mediates low cell-cycle activity and increases the proportion of long-term–reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol 2010; 38:301-310. e302.
58. Desplat V, Faucher J-L, Mahon FX, Sbarba PD, Praloran V, Ivanovic Z. Hypoxia modifies proliferation and differentiation of CD34+ CML cells. Stem Cells 2002; 20:347-354.
59. Jiang J, Wang W, Zhu L, Shi B, Chen Y, Xia Y, et al. Unveiling the role of hypoxic macrophage-derived exosomes in driving colorectal cancer progression. Front Immunol 2023; 14:1260638.
60. Li X, Fang S, Wang S, Xie Y, Xia Y, Wang P, et al. Hypoxia preconditioning of adipose stem cell-derived exosomes loaded in gelatin methacryloyl (GelMA) promote type H angiogenesis and osteoporotic fracture repair. J Nanobiotechnology 2024; 22:112.
61. Liu W, Rong Y, Wang J, Zhou Z, Ge X, Ji C, et al. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J Neuroinflammation 2020; 17:47.
62. de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 2012; 1:18396.
63. Mo F, Xu Y, Zhang J, Zhu L, Wang C, Chu X, et al. Effects of hypoxia and radiation-induced exosomes on migration of lung cancer cells and angiogenesis of umbilical vein endothelial cells. Radiat Res 2020; 194:71-80.
64. Deep G, Jain A, Kumar A, Agarwal C, Kim S, Leevy WM, et al. Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinase activity at pre-metastatic niches. Mol Carcinog 2020; 59:323-332.
65. Thankam FG, Chandra I, Diaz C, Dilisio MF, Fleegel J, Gross RM, et al. Matrix regeneration proteins in the hypoxia-triggered exosomes of shoulder tenocytes and adipose-derived mesenchymal stem cells. Mol Cell Biochem 2020; 465:75-87.
66. Wang Y, Cen A, Yang Y, Ye H, Li J, Liu S, et al. miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis. Mol Ther Nucleic Acids 2021; 24:610-621.
67. Tomazin K. Characterization of exosomes from glioma cells under hypoxia [Internet]. Lund (Sweden): Lund University; 2015 [cited 2025 Dec 23]. Master’s thesis. Available from: http://lup.lub.lu.se/student-papers/record/5271385.